Receive news by e-mail

#
 

Enter your e-mail in the field below to receive directly the news that appears on this page.

 

topics : related - all Explore

Shopping

Top Product

Why Bank Regulation Failed: Designing a Bank Regulatory Strategy for the 1990s

Compare prices

Shopping Categories

  1. 1. Cell Phones
  2. 2. Smartphones
  3. 3. Digital Cameras
  4. 4. Laptop Computers
  5. 5. Processors
  6. 6. Motherboards
  7. 7. LCD Monitors
  8. 8. Graphics Cards
  9. 9. GPS
  10. 10. Digital Camcorders
  11. 11. Printers
  12. 12. Desktop Computers
  13. 13. Sedans
  14. 14. Coupes & Convertibles
  15. 15. 4x4

Wikio Shopping

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Books
  4. 4. Car/Motorbike
  5. 5. CD
  6. 6. Clothing, Accessories & Shoes
  7. 7. Communication
  8. 8. Computers
  9. 9. DVD
  10. 10. Electronics
  11. 11. Flowers & Gifts
  12. 12. Gourmet & Foods
  13. 13. Health & Personal Care
  14. 14. Home & Garden
  15. 15. Hotels
  16. 16. Household Appliances
  17. 17. Jewelry & Watches
  18. 18. Musical Instruments
  19. 19. Sports & Outdoors
  20. 20. Toys & Baby
  21. 21. Video Games

Participate



Regulatory Strategy



Sort by : relevance - date
4Vote!

Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs

TUSTIN, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that Dr. Robert Garnick has joined the company as the head of regulatory affairs. Dr. Garnick was formerly the senior vice president of regulatory, quality and compliance at Genentech. During his 24-year career at Genentech, he was responsible for 17 new product approvals...

3Vote!

EpiCept Corporation Announces Health Canada Accepts Ceplene(R) Application For Review

... is within 300 days. "We are pleased to have completed another key milestone in our North American regulatory strategy for Ceplene®," stated Jack Talley, President and Chief Executive Officer of EpiCept. "As the next step in this process, we are focused on the filing of a New Drug Application for Ceplene® with the U.S. Food and Drug Administration for AML remission maintenance. As...

4Vote!

Micromet takes back MedImmune's blinatumomab rights

... development and commercialization of blinatumomab, Micromet can develop an integrated clinical and regulatory strategy across multiple commercial territories, starting with the first pivotal study that we expect to initiate in 2010." - read Micromet's release Related Articles: Micromet inks $475M antibody deal with Sanofi Micromet raising up to $80M to fund acquisitions, research...

5Vote!

IBC Life Sciences: IBC Life Sciences Announces Biopharmaceutical Development & Production Week March 1-5, 2010 in Carlsbad, California

... Learned and Where are We Going? A CMO's Perspective John McGrath, Lonza Biologics -- Global Regulatory Strategies for Validation and Transfer of Biotech Processes and Products Robert L. Garnick, Ph.D., Lone Mountain Biotechnology and Medical Devices, Inc. -- The Critical Elements of a Successful Regulatory Filing for Outsourcing Biopharmaceutical Manufacturing Terry...

4Vote!

AcelRx Announces Successful Completion of End-of-Phase 2 Meeting on ARX-01, Sufentanil NanoTab PCA System for Post-Operative Pain Management

... surgery and abdominal surgery. The FDA provided AcelRx with guidance on Phase 3 study design, regulatory strategy, and NDA requirements. Commenting on the meeting, Pamela Palmer, MD, PhD, AcelRx Chief Medical Officer stated, "We are glad to have FDA input on the NDA requirements for this novel approach to post-operative pain management. Given this guidance, our path to market...

4Vote!

AcelRx Announces Successful Completion of End-of-Phase 2 Meeting on ARX-01, Sufentanil NanoTab PCA System for Post-Operative Pain Management

... surgery and abdominal surgery. The FDA provided AcelRx with guidance on Phase 3 study design, regulatory strategy, and NDA requirements. Commenting on the meeting, Pamela Palmer, MD, PhD, AcelRx Chief Medical Officer stated, "We are glad to have FDA input on the NDA requirements for this novel approach to post-operative pain management. Given this guidance, our path to market is now...

3Vote!

Federal Register: Radiological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting

The committee will discuss and make recommendations regarding the agency's regulatory strategy for Full Field Digital Mammography (FFDM) Devices.

3Vote!

Executive Moves: Peregrine Pharmaceuticals

Dr. Robert Garnick has joined Peregrine Pharmaceuticals as the head of regulatory affairs. Dr. Garnick was formerly the senior vice president of regulatory, quality and compliance at Genentech. During his 24-year career at that company, he was responsible for 17 new product approvals, including most of the company's top selling monoclonal antibody therapeutics such as Rituxan, Herceptin,...

3Vote!

Constellation Aviation Consultancy launches

... to offer a comprehensive range of services to airlines and start-up carriers at a time when regulatory hurdles are exceptionally challenging. Their offering includes tailored start-up support packages for new entrant operators. With backgrounds in airline operations, airline start-ups, licensing and management, finance, law and aviation IT, Constellation’s directors will lend support and...

3Vote!

Constellation Aviation Consulting launches as new ‘one-stop shop’ airline consultancy

Five aviation professionals combining the depth of expertise that you would typically find in an airline’s boardroom have joined forces to create an all new advisory agency - Constellation Aviation Consulting Limited (CACL). Based in Central London, the associates are pooling their resources and skillsets to offer a comprehensive range of services to airlines and start-up carriers at a time when regulatory...

4Vote!

Foresight Biotherapeutics Establishes Scientific Advisory Board

... of Ophthalmology. These highly regarded experts will advise the company on its clinical programs, regulatory strategy and provide strategic guid

4Vote!

don duncan, asa: cm zine says ordinance that doesn’t recognize sales of medical cannabis won’t work in LA (2013)

... cannabis collective. Instead, the ordinance seeks to regulate collective patient gardens – a regulatory strategy rejected by the committee earlier this year. The City Attorney arranged for a parade of officials to reinforce his position that sales of cannabis are illegal in all circumstances. Representatives from the Long Beach District Attorney and City Attorney’s offices inexplicably...